NeuroOne Medical Technologies Corporation is a medical - devices company in the healthcare sector trading on NASDAQ, led by CEO David A. Rosa, with a market cap of $37.4M.
Common questions about NeuroOne Medical Technologies Corporation
NeuroOne Medical Technologies Corporation is scheduled to report earnings for Q2 2026 on May 12, 2026. Analysts estimate revenue of $2.6M.
NeuroOne Medical Technologies Corporation has approximately 16 employees.
We use cookies for analytics. See our Privacy and Cookie Policy.